Replies to post #665942 on NorthWest Biotherapeutics Inc (NWBO)

[JTORENCE]

Guzzi62 How come ABC news is PR' this treatment and not a peep about NWBO .
Is NWBO considered a Republican owned company and we all know that ABC is a far left media channel??

[snoopycomic]

I read this News coverage, and I was shocked that they are not even aware of Northwest Bio. It is a sad vast conspiracy orchestrated by Big Pharma imo.

[flipper44]

This has already been discussed, but here are some of my previous thoughts.

I just want to make one more point on the Elios tlpo versus tlpodc phase ii disease free melanoma trial and show you how they are working like Novocure does. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401209/

Look at the link/figure below. Now realize that based upon this, they’re currently saying, well since tlpo and tlpodc are essentially equal, we should do a phase iii on tlpo because we can’t really afford to keep trialing tlpodc.

But wait a minute, look at cases at risk at thirty and 36 months.🤨 By 36 months, which is what they go by in their trial “survival section,” only one, that’s right, one data point was used to get their survival number for tlpo.😬 But look, they matured the tlpodc group and let 19 cases be at risk for the 36 month analysis.

You see what they did there? They didn’t bother to build a DC manufacturing base like NWBO, so apparently they said fck it, let’s just get one good 36 month data point and call it a day, so that we don’t have to build up an industry. (They also only had six tlpo data points at 30 months)

(Note: remember the Elios (Orbus Therapeutic’s parent) trial was for melanoma)

https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=10401209_jitc-2023-006665f02.

[exwannabe]

Another competitor but far behind us, using almost same approach as I understand it,

Kind of odd that people keep calling any ATL-DC the same as NWBO's

There have been dozens (maybe hundreds) of ATl-DC trials. Longs here argue (and potentially with merit) that NWBO has somehow done it better. But then they say anything else is just the same.

The Elios TLPODC concept is clearly different in how the ATL-DC is manufactured. But still in the same class as DC-L.

The Elios TLPO concept though is not even an ATL-DC. It is a very different product. It takes the lysate, encapsulated in particle that uses yeast cell wall lining to enclose it, and injects that into the patient. The idea is that the DC's (and other APCs) will recognize and react to it n vivo, as God designed..

I nether know nor care how it actually works. But the idea that all ATL-DC's are NWBO clones is just funny when NWBO was not the first and in no way owns the space.